| Literature DB >> 32030020 |
Srinivas Bairy1, M Raghavendra Rao2, Srinivas Reddy Edla1, Satyanarayana Raju Manthena1, N V Gnana Deep Tatavarti1.
Abstract
AIM: Lifestyle is an important risk factor for increasing the prevalence of diabetes in the Indian population. In this study, we evaluate the effects of naturopathy treatment, salt-restricted low-calorie diets, and yoga in long-term glycemic control in patients with type 2 diabetes mellitus.Entities:
Keywords: Diabetes; fasting; glycemic control; low-salt diet; naturopathy; yoga
Year: 2020 PMID: 32030020 PMCID: PMC6937879 DOI: 10.4103/ijoy.IJOY_32_19
Source DB: PubMed Journal: Int J Yoga ISSN: 0973-6131
Figure 1Trial profile
Sociodemographic and clinical characteristics of the study population
| Particulars | Mean±SD | |
|---|---|---|
| Naturopathy | Conventional | |
| Age, mean±SD | 51.0±8.1 | 48.8±8.1 |
| Duration of type 2 diabetes mellitus | 10.27±6.6 | 5.83±5.7 |
| Gender, | ||
| Male | 43 (42.2) | 50 (45.9) |
| Female | 59 (57.8) | 59 (54.1) |
| No comorbidity | 35 (34.3) | 31 (28.4) |
| Comorbidity 1 | 48 (47.1) | 65 (59.6) |
| Comorbidity 2 | 18 (17.6) | 12 (11.0) |
| Comorbidity 3 | 1 (1.0) | 1 (0.9) |
| Comorbidity obesity | 28 (27.5) | 37 (33.9) |
| Comorbidity hypertension | 46 (45.1) | 47 (43.1) |
| Comorbidity hypothyroidism | 3 (2.9) | 5 (4.6) |
| Comorbidity CAD | 3 (2.9) | 0 (0.0) |
| Comorbidity nephropathy Grade 1 | 7 (6.9) | 3 (2.8) |
| Comorbidity others | 36 (35.3) | 16 (14.7) |
| Occupation, | ||
| Government employee | 1 (1.0) | 2 (1.8) |
| Nongovernment employee/private | 9 (8.8) | 10 (9.2) |
| Homemaker | 56 (54.9) | 40 (36.7) |
| Retired employee | 11 (10.8) | 5 (4.6) |
| unemployed | 5 (4.9) | 2 (1.8) |
| Business | 3 (2.9) | 2 (1.8) |
| Others | 17 (16.7) | 48 (44.0) |
| Education, | ||
| Illiterate | 5 (4.9) | 31 (28.4) |
| Less than primary | 4 (3.9) | 8 (7.3) |
| Primary | 24 (23.5) | 24 (22.0) |
| High school | 31 (30.4) | 30 (27.5) |
| Intermediate | 12 (11.8) | 8 (7.3) |
| Graduate | 22 (21.6) | 5 (4.6) |
| Postgraduate | 4 (3.9) | 3 (2.8) |
SD=Standard deviation, CAD=Coronary artery disease
Comparison of changes in fasting and postprandial blood sugar over time following naturopathy and conventional treatment using repeated-measures ANOVA
| Group | FBG (mg/dl), mean±SD | FBG change score (mg/dl), mean±SD | |||||
|---|---|---|---|---|---|---|---|
| BL | 3 M | 6 M | 12 M | 3 M | 6 M | 12 M | |
| Naturopathy | 190.66±65.51 | 136.10±44.93** | 144.13±53.40** | 167.09±58.45* | 54.56±65.51 | 46.53±72.48 | 23.57±75.70 |
| Conventional | 148.54±46.62 | 136.82±38.71 | 150.00±57.48 | 157.33±62.60 | 10.35±49.64 | −0.35±49.64 | −0.35±49.640 |
| Naturopathy | 250.69±104.13 | 172.31±56.15** | 184.10±63.90** | 273.13±81.69 | 73.47±114.02 | 61.67±108.99 | −1.67±108.99* |
| Conventional | 212.40±77.04 | 183.73±55.14* | 195.64±63.49 | 202.19±87.50 | 26.72±81.04 | 14.81±87.08 | 8.96±96.88 |
P<0.008, P<0.01 for between groups; *P<0.008, **P<0.001 for within group effects using post hoc Bonferroni correction. BL=Baseline, 3 M=3 months, 6 M=6 months, 12 M=12 months, FBG=Fasting blood sugar, SD=Standard deviation
Comparison of changes in glycated hemoglobin over time following naturopathy and conventional treatment using repeated-measures ANOVA with post hoc Bonferroni correction
| HbA1c (%), mean±SD | HbA1c change score (%), mean±SD | ||||||
|---|---|---|---|---|---|---|---|
| Baseline | 3 M | 6 M | 12 M | 3 M | 6 M | 12 M | |
| Naturopathy group | 9.6 (81)±1.8 (19) | 7.5 (58)±0.8 (8)** | 7.9 (63)±1.5 (16)** | 8.5 (69)±1.7 (18)** | 2.0 (21)±1.6 (17) | 1.6 (17)±2.0 (21) | 1.1 (12)±2.0 (21) |
| Conventional group | 9.0 (75)±1.7 (18) | 8.2 (66)±1.2 (13)** | 8.4 (68)±1.6 (17)* | 8.4 (68)±1.7 (18) | 0.7 (7)±1.7 (18) | 0.6 (6)±1.8 (19) | 0.5 (5)±1.8 (19) |
P<0.008, P<0.001, for between groups; *P<0.008, **P<0.01 for within group effects using post hoc Bonferroni correction, HbA1c values in mmol/mol is in parentheses. SD=Standard deviation, BL=Baseline, 3 M=3 months, 6 M=6 months, 12 M=12 months, HbA1c=Glycated hemoglobin
Comparison of medication score of the study population at baseline, 3, 6, and 12 months using Diabetes Medication Satisfaction Tool
| Total score, mean±SD | ||||
|---|---|---|---|---|
| Base line | 3 M | 6 M | 12 M | |
| Naturopathy group | 1.62±0.90 | 1.16±0.95 | 0.79±0.90ł | 0.75±0.93 |
| Conventional group | 1.55±0.83 | 1.24±1.02 | 1.18±1.08 | 0.82±1.06 |
P<0.008 for between groups using Mann–Whitney U-test. BL=Baseline, 3 M=3 months, 6 M=6 months, 12 M=12 months, SD=Standard deviation
Parenteral medication (insulin) score at baseline, 3, 6, and 12 months
| Parenteral insulin | BL, | 3 M, | 6 M, | 12 M, | ||||
|---|---|---|---|---|---|---|---|---|
| Yes | No | Yes | No | Yes | No | Yes | No | |
| Naturopathy group | 36 (35.5) | 66 (64.7) | 23 (22.5) | 79 (77.5) | 18 (17.6) | 84 (82.4) | 15 (14.7) | 87 (85.3) |
| Conventional group | 36 (33.3) | 72 (66.7) | 34 (31.5) | 74 (68.5) | 32 (29.6) | 76 (70.4) | 21 (19.4) | 87 (80.6) |
| 0.76 | 0.14 | 0.04 | 0.36 | |||||
P<0.05, P<0.01, P<0.001 for between groups using Chi-square test of proportions. BL=Baseline, 3 M=3 months, 6 M=6 months, 12 M=12 months